Nephrospec™ is a non-invasive technology that uses low-intensity acoustic waves applied externally to the kidney region. The technology has been studied in clinical contexts related to Chronic Kidney Disease and should be used according to medical evaluation and indication.
Nephrospec™ employs low-intensity acoustic waves applied externally to the renal region. The procedure is performed in a clinical setting, in accordance with a defined protocol and the evaluation of the attending physician.
Nephrospec™ uses eHAT (Electro-Hydraulic Acoustic Therapy) technology, based on the application of low-intensity acoustic waves directed externally to the renal region. The procedure is performed according to a clinical protocol and under the supervision of a physician.
Targeted approach to the renal region and studied in contexts related to kidney function.
Technology evaluated in clinical and pre-clinical studies.
Clinical and pre-clinical studies, scientific presentations, and technical materials on Nephrospec™ are available in the Physician's Area, with restricted access to registered physicians.
Nephrospec™ is a technology developed by Curespec and intended for use in accordance with applicable regulatory requirements in each market.
In Brazil, the availability of the product must comply with the registration and use conditions established by the competent health authority.
